Prosztatarák: vizsgálatok itt: Németország
97 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisNot yet taking people in NémetországOpen-label clinical phase 1/2 study to assess the safety and efficacy of the SpectraCure P18 System and verteporfin for injection for the treatment of primary localized prostate cancer
- Where
- Köln, Rostock
- Életkor
- 18 év and over
- People
- 20
- Run by
- SpectraCure AB (publ)
See details and how to join2024-519658-35-00 - No phaseTaking peopleImmune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
- Where
- Augsburg, Erlangen, Munich
- Életkor
- 18 év and over
- People
- 200
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT07131956 - 3. fázisTaking peopleA Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
- Where
- Dresden, Essen, Freiburg, Jena, München, Munich, Rostock, Tuebingen, Ulm
- Életkor
- 18 év and over
- People
- 3360 worldwide
- Run by
- University College, London
See details and how to joinNCT06320067 · EU 2025-522145-21-00 - No phaseTaking peopleEvaluation of Needs of Patients and Care-givers During and After Radiotherapy of Patients With Prostate Cancer
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 60
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07156903 - No phaseTaking peopleLiquid Biopsy Under PSMA Radioligand Therapy
- Where
- Augsburg, München, Würzburg
- People
- 100
- Run by
- Wuerzburg University Hospital
See details and how to joinNCT07118436 - 3. fázisNot yet taking people in NémetországPSMA PET For intermediate- or high-risk prostate cancer prior to RadioTherapY: A prospective interventional randomized clinical trial (P4RTY)
- Where
- Essen
- Életkor
- 18 év and over
- People
- 352
- Run by
- Universitaetsklinikum Essen AöR
See details and how to join2023-506032-33-00 - No phaseNot yet taking people in NémetországReminder App to Optimize Bladder Filling During Radiotherapy for Prostate Cancer
- Where
- Flensburg, Hanover, Lübeck, Schwerin
- Életkor
- 18 év and over
- People
- 28 worldwide
- Run by
- University Hospital Schleswig-Holstein
See details and how to joinNCT06653751 - No phaseNot yet taking people in NémetországEuropean Registry of Next Generation Imaging in Advanced Prostate Cancer
- Where
- Bonn, Hamburg, Munich, Planegg, Tübingen
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Fundacio Puigvert
See details and how to joinNCT06866782 - No phaseTaking peopleA Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET
- Where
- Augsburg, Munich
- Életkor
- 18 év and over
- People
- 94
- Run by
- Technical University of Munich
See details and how to joinNCT06859203 - No phaseTaking peopleImpact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer
- Where
- Düsseldorf
- Életkor
- 18 év and over
- People
- 200
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06820333 - No phaseNot yet taking people in NémetországA Reminder App to Optimize Bladder Filling in Patients with Prostate Cancer Receiving HYPO-fractionated Radiotherapy
- Where
- Hanover, Lübeck
- Életkor
- 18 év and over
- People
- 27 worldwide
- Run by
- University Hospital Schleswig-Holstein
See details and how to joinNCT06784115 - No phaseTaking peopleDiagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
- Where
- Düsseldorf
- Életkor
- 18 év and over
- People
- 250
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06657131 - 1. fázisTaking peopleThe Bispecific PSMAxCD3 Antibody CC-1 in Patients with Castration Resistant Prostate Carcinoma
- Where
- Berlin, Tuebingen
- Életkor
- 18 év and over
- People
- 86
- Run by
- University Hospital Tuebingen
See details and how to joinNCT04104607 · EU 2024-512894-29-00 - No phaseTaking peopleKidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial
- Where
- Munich
- Életkor
- 18 év and over
- People
- 100
- Run by
- Hannah Schaefer
See details and how to joinNCT06720532 - 1. fázisTaking peopleAntibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer
- Where
- Tuebingen
- Életkor
- 18 év and over
- People
- 56
- Run by
- University Hospital Tuebingen
See details and how to joinNCT05646550 · EU 2024-511430-12-00 - No phaseTaking peopleImage-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rt
- Where
- Freiburg im Breisgau
- Életkor
- 18 év and over
- People
- 374
- Run by
- University Hospital Freiburg
See details and how to joinNCT06330909 - No phaseTaking peoplePROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer
- Where
- Essen
- Életkor
- 18 év and over
- People
- 10 000
- Run by
- University Hospital, Essen
See details and how to joinNCT06320223 - 2. fázisNot yet taking people in NémetországHyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 110
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT04889742 - No phaseTaking peopleOnline Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 649
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT06116019 - No phaseTaking peopleFeasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
- Where
- Tübingen
- Életkor
- 18 év and over
- People
- 472
- Run by
- University Hospital Tuebingen
See details and how to joinNCT04172753 - No phaseTaking peopleStudy of MR-based IGRT for Prostate Cancer
- Where
- Tübingen
- Életkor
- 18 év and over
- People
- 78
- Run by
- University Hospital Tuebingen
See details and how to joinNCT02724670 - 2. fázisTaking peopleFocal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial
- Where
- Erlangen
- Életkor
- 18 év and over
- People
- 50
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT02391051